results from checkmate-032, nivolumab and ipilimumab for melanoma
Published 5 years ago • 77 plays • Length 5:56Download video MP4
Download video MP3
Similar videos
-
2:09
checkmate 032: nivolumab/ipilimumab for urothelial carcinoma
-
3:59
checkmate 067 - combined nivolumab and ipilimumab
-
2:48
checkmate067 outcomes: nivolumab plus ipilimumab in advanced melanoma
-
1:13
checkmate 067: nivolumab plus ipilimumab combination therapy in advanced melanoma
-
9:14
results from checkmate-227 : immune combination reaches pfs endpoint
-
11:58
checkmate 214: nivolumab ipilimumab or sunitinib in patients with advanced renal cell carcinoma
-
6:12
nivolumab vs ipilimumab for high risk melanoma patients
-
5:44
4-year results from checkmate 238: adjuvant nivo vs ipi in resected stage iii/iv melanoma
-
2:31
dr. wolchok on updated checkmate-067 results for melanoma
-
5:18
neoadjuvant ipilimumab and nivolumab immunotherapy for resectable stage iii melanoma
-
2:22
adjuvant nivolumab in patents with high-risk resected melanoma
-
1:49
the significance of the ipilimumab/nivolumab findings in melanoma
-
2:01
checkmate 172 trial of nivolumab for advanced melanoma: preliminary results
-
3:16
melanoma patients who discontinued nivolumab and ipilimumab experienced equal or better pfs
-
1:55
neoadjuvant ipilimumab plus nivolumab in stage iii melanoma
-
0:57
dr. postow on os results of checkmate-069 study
-
3:30
dosing regiment in the combination of ipilimumab and nivolumab in stage iii melanoma
-
1:59
checkmate 238: nivolumab versus ipilimumab in stage iii melanoma
-
6:19
should you treat melanoma with nivolumab and relatlimab (opdualag)?